New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 29, 2013
05:57 EDTONTXOnconova Therapeutics upgraded to Buy from Neutral at Citigroup
Citigroup upgraded Onconova Therapeutics citing a favorable risk/reward following the recent pullback in shares. Citi lowered its price target for the stock to $27 from $30.
News For ONTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 13, 2014
16:06 EDTONTXOnconova reports Q3 EPS (69c), consensus (75c)
Reports Q3 revenue $114K, consensus $0. Cash, cash equivalents, and marketable securities as of September 30 totaled $57.3M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use